Kelly Elise Dooley

Associate Professor

20022020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Kelly Elise Dooley is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 27 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • Dolutegravir-based Antiretroviral Therapy for Patients Coinfected with Tuberculosis and Human Immunodeficiency Virus: A Multicenter, Noncomparative, Open-label, Randomized Trial

    Dooley, K. E., Kaplan, R., Mwelase, N., Grinsztejn, B., Ticona, E., Lacerda, M., Sued, O., Belonosova, E., Ait-Khaled, M., Angelis, K., Brown, D., Singh, R., Talarico, C. L., Tenorio, A. R., Keegan, M. R., Aboud, M., Dooley, K. E., Richard, K., Noluthando, M., Beatriz, G. & 44 others, Eduardo, T. C., Marcus, L., Omar, S., Elena, B., Mounir, A. K., Konstantinos, A., Dannae, B., Rajendra, S., Talarico, C. L., Tenorio, A. R., Keegan, M. R., Michael, A., Sergio, L., Pedro, C., Norma, P., Gustavo, D. L., Breno, R. S., Jose, M., Carlos, R. A., Nora, P. Q. P., Eduardo, R. N., Alma, P. R., Santiago, P. P., Juan-Luis, M. G., Mercedes, P. P., Aldo, R., John, M. R., Wilfredo, C., Eduardo, S. V., Elena, B., Lenar, S., Elvira, I., Alexey, Y., Alexander, P., Rodney, D., Gulam, L., Lerato, M., Jantjie, T., Johannes, J. L., Mohammed, K., Ebrahim, V., Ploenchan, C., Sasisopin, K. & Anchalee, A., Feb 3 2020, In : Clinical Infectious Diseases. 70, 4, p. 549-556 8 p.

    Research output: Contribution to journalArticle

    Open Access
  • High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial

    The AIDS Clinical Trials Group and the Tuberculosis Trials Consortium, Mar 2020, In : Contemporary Clinical Trials. 90, 105938.

    Research output: Contribution to journalArticle

  • Integrating pharmacokinetics and pharmacodynamics in operational research to end tuberculosis

    Alffenaar, J. W. C., Gumbo, T., Dooley, K. E., Peloquin, C. A., McIlleron, H., Zagorski, A., Cirillo, D. M., Heysell, S. K., Silva, D. R. & Migliori, G. B., Apr 15 2020, In : Clinical Infectious Diseases. 70, 8, p. 1734-1780 47 p.

    Research output: Contribution to journalReview article

    Open Access
  • Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trial

    Dooley, K. E., Savic, R., Gupte, A., Marzinke, M. A., Zhang, N., Edward, V. A., Wolf, L., Sebe, M., Likoti, M., Fyvie, M. J., Shibambo, I., Beattie, T., Chaisson, R. E. & Churchyard, G. J., Jun 2020, In : The Lancet HIV. 7, 6, p. e401-e409

    Research output: Contribution to journalArticle